3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
10
Leukemia, Myeloid, Acute
9
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Multiple Myeloma
5
Lymphoma, Large B-Cell, Diffuse
5
Small Cell Lung Carcinoma
4
Sarcoma
4
Recurrence
4
Neuroblastoma
4
Central Nervous System Neoplasms
4
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Teratoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Optic Nerve Glioma
2
Oligodendroglioma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Congenital Abnormalities
2
Breast Neoplasms
2
Interventions
Valganciclovir
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
Nivolumab
2
tocilizumab
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
emvododstat
1
efineptakin alfa
1
cabozantinib
1
Zidovudine
1
Sunitinib
1
Polymerase Chain Reaction
1
Nelfinavir
1
Maraviroc
1
Lenalidomide
1
Ipilimumab
1
Immunohistochemistry
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Etoposide
1
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
CTLA-4 Antigen
1
Antiretroviral Therapy, Highly Active
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Kaposi
×
etoposide phosphate
×
Clear all
No trials found.